Bharat Immunologicals

Rediff.com » News » Bharat Immunologicals

News for Bharat Immunologicals

News
Business

Govt denies pressuring Covaxin makers for early release of vaccine

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......

Covaxin's 50 pc efficacy adequate for Covid, say experts

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor......

Ideal time for Covid booster is 6 months after 2nd dose: Covaxin maker

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said on Wednesday, and also emphasised the......

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech ......

Covid-19 impact: Low interest loans likely for vaccine companies

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made......

Covaxin: How Bharat Biotech plans to boost immunity

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed. Hyderabad based Bharat Biotech, whose Covid-19 vaccine......

Covid vaccine: Pharma firms ready expansion plans

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......

Serum Institute's race to produce COVID-19 vaccine

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......

Rediff News

Bharat Immunologicals

News for Bharat Immunologicals

Govt denies pressuring Covaxin makers for early release of vaccine

Covaxin's 50 pc efficacy adequate for Covid, say experts

Ideal time for Covid booster is 6 months after 2nd dose: Covaxin maker

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Bharat Biotech starts Covaxin's at-risk manufacture

Covid-19 impact: Low interest loans likely for vaccine companies

Covaxin: How Bharat Biotech plans to boost immunity

Covid vaccine: Pharma firms ready expansion plans

Serum Institute's race to produce COVID-19 vaccine

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS